Companion Animal Diagnostics Market Report 2026-2031, By Product, Technology, and Geo

Companion Animal Diagnostic Market by Product (Consumable, Instrument), Technology (Immunodiagnostic, ELISA, PCR Test, Urinalysis, Hematology), Animal Type (Dog, Cat), Application (Clinical Pathology, Virology), End User - Global Forecast to 2031

USD 5.40 BN

MARKET SIZE, 2031

CAGR 8.7%

(2026-2031)

450

REPORT PAGES

400

MARKET TABLES

COMPANION ANIMAL DIAGNOSTIC MARKET SIZE, SHARE & GROWTH SNAPSHOT

companion-animal-diagnostic-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global companion animal diagnostics market is projected to grow from USD 3.56 billion in 2026 to USD 5.40 billion by 2031, at a CAGR of 8.7% during the forecast period. The market was valued at USD 3.29 billion in 2025. Factors driving the companion animal diagnostics market include the rising demand for rapid and accurate diagnostic testing, the surging use of advanced technologies such as molecular diagnostic tests and AI-based analyzers, and the growing focus on preventive and early diagnostic testing for companion animals. Moreover, the increasing cases of chronic and contagious diseases have forced veterinary diagnostic centers to adopt accurate high-performing diagnostic solutions.

KEY TAKEAWAYS

By Region

The North American companion animal diagnostics market accounted for a share of 47.9% in 2025.
By Product

By product, the instruments segment is expected to register the highest CAGR of 9.8% from 2026 to 2031.
By Technology

By technology, the immunodiagnostics segment dominated the market by accounting for a 33.0% share in 2025.
By Application

By application, the clinical pathology segment dominated the market, accounting for 52.7% in 2025.
By Animal Type

By animal type, the cats segment is projected to record the highest CAGR from 2026 to 2031.
By End User

By end user, the veterinary hospitals & clinics segment dominated the market, accounting for 62.0% in 2025.
Competitive Landscape - Key Players

IDEXX Laboratories, Inc.; Zoetis Services LLC; and Antech Diagnostics, Inc. were identified as some of the star players in the companion animal diagnostics market, given their extensive global reach and comprehensive product portfolios.
Competitive Landscape - Startups

Gold Standard Diagnostics, Biopanda Reagents Ltd, and Fassisi GmbH, among others, have distinguished themselves among startups and SMEs through specialized veterinary expertise and focused product capabilities.

The market for companion animal diagnostics is growing robustly, in large part due to rising expenditures on household pet healthcare, growing interest in rapid, accurate testing, and the general acceptance and use of state-of-the-art diagnostic technology. Novel technologies with market potential for companion animal diagnostics include image analysis using artificial intelligence, cloud-connected analyzers, liquid biopsy platforms, and wearable health monitors. Moreover, the growing interest in partnerships among industry stakeholders is fueling the development process.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The impact to the consumer businesses in the companion animal diagnostics market stems from an increasing need for pet healthcare, increased disease complexity, and the rapid development of diagnostic tools and technologies. Animal healthcare businesses, veterinary practices, and laboratories are highly dependent on sophisticated diagnostic equipment, in-office rapid testing solutions, and AI-based solutions to boost accuracy, improve work flows, and enable fast diagnostic decisions. The need to deliver data-driven, preventive, and precision-based pet healthcare practices, and transform their operational models to accommodate integrated diagnostic environments and cloud-based solutions, are highly contributing to these significance to the consumer businesses. The demand for fast, accurate, and comprehensive diagnostic solutions and practices creates an increased dependency on innovative diagnostic solution partners, thereby accelerating market growth. There is a shift in the companion animal diagnostics business from conventional and routine testing to modern and technology-driven diagnostic solutions, which are expected to be the catalyst for future business revenues. The current method of revenue generation mainly focuses on conventional and routine testing for hematology, clinical chemistry, immunodiagnostics, and routine urinalysis and fecal analysis, while the future method will focus on molecular diagnostics, AI-based analysis, integrated diagnostic solutions, and at-home/remote patient monitoring. At present, diagnostic labs, veterinary hospitals, clinics, and research organizations need faster, higher-speed, and more precise solutions to detect and diagnose diseases in companion animals. These new testing and diagnostic solutions are likely to be in high demand in the near future to deliver improved medical outcomes for better disease diagnosis and treatment. These new kinds of testing and diagnostic solutions will also be expected to take care of the quality of overall veterinary medical solutions and services.

companion-animal-diagnostic-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers

Impact
Level

Growing companion animal ownership
Rising demand for pet insurance and increased spending on animal healthcare

RESTRAINTS

Impact
Level

High cost of diagnostic devices
Stringent regulations and lengthy approval processes for diagnostic products

OPPORTUNITIES

Impact
Level

Growing demand for rapid tests and portable instruments for PoC diagnostics
Integration of AI and ML for enhanced disease diagnosis

CHALLENGES

Impact
Level

Shortage of veterinary practitioners in emerging markets
Barriers to adoption in small clinics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Growing companion animal ownership

The increasing number of companion animals, especially in developed and emerging regions, is a key enabler of the companion animal diagnostics market growth. As people increasingly own companion animals, especially the younger population, the need for their healthcare, including diagnostics, is increasing substantially. With companion animals increasingly being accepted within families and treated as an integral part of them, their owners tend to spend on their healthcare checks and preventive care. These companion animals lead to an increased number of diagnostic procedures being performed, thereby driving the market for diagnostics in the veterinary segment.

Restraint: High cost of diagnostic devices

One of the key restraints for the adoption of advanced diagnostic solutions across the companion animal segment is the high investment required for the use of these diagnostic solutions. Solutions ranging from advanced molecular diagnostics tools to advanced point-of-care instruments also pose high investment costs to the users. This proves to be an area of concern for the smaller veterinary setups, mainly the ones existing in developing regions with less access to investment and monetary budgets. Despite the potential offered through advanced diagnostic solutions regarding accuracy and time efficiency, the cost component remains an area of hindrance to the adoption of these solutions across the companion animal segment.

Opportunity: Growing demand for rapid tests and portable instruments for PoC diagnostics

The growing demand for quick diagnostic solutions and portable point-of-care (PoC) diagnostic instruments is a significant opportunity available in the companion animal diagnostic segment. This is because the instruments have the capability of providing fast and accurate results within veterinary settings. Additionally, the growing home veterinary care services trend and the adoption of telemedicine create a new and unmet need for working PoC diagnostic instruments within this segment. This is especially the case given the increased interest in and focus on preventive healthcare and early disease detection.

Challenge: Shortage of veterinary practitioners in emerging markets

A major factor challenging the market's growth is a lack of qualified veterinary practitioners in most emerging markets. In most regions, because only a few professionals are trained to handle advanced diagnostic technologies, this hampers the effective utilization of these tools. For instance, there exists an imbalance in various regions of the world between rural and urban areas, with the former possessing skilled professionals and better diagnostic facilities, while the latter most often lacks sufficient veterinary professionals or diagnostic facilities. This leads to slow adoption and integration of newer diagnostic technologies, becoming a bottleneck to growth and resulting in restricted access to modern veterinary diagnostics in many underprivileged regions.

COMPANION ANIMAL DIAGNOSTIC MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY	USE CASE DESCRIPTION	BENEFITS
	Provides in-clinic and reference laboratory diagnostic products for companion animals, including clinical chemistry, hematology, immunoassays, urinalysis systems, and rapid diagnostic tests	Enables fast and accurate diagnosis \| Supports preventive care \| Improves clinical decision-making in veterinary practices
	Offers point-of-care diagnostic analyzers and rapid tests for companion animals, covering clinical chemistry, hematology, and immunodiagnostic testing	Improves diagnostic efficiency \| Supports earlier disease detection and treatment decisions
	Produces and distributes companion animal diagnostic testing kits and laboratory analyzers used for clinical pathology and specialty diagnostics	Provides access to advanced diagnostic assays and consistent test performance across high-throughput laboratory environments
	Supplies microbiology and immunodiagnostic instruments and reagents used for detecting infectious diseases in companion animals	Improves pathogen detection accuracy \| Supports reliable, reproducible laboratory diagnostics
	Markets rapid diagnostic test kits and immunodiagnostic products for companion animals alongside its therapeutic portfolio	Supports early diagnosis \| Improves treatment selection through quick, easy-to-use tests

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The ecosystem of the companion animal diagnostics market includes a broad range of stakeholders, each with an important role in the development, distribution, and end-use of diagnostic solutions. At the forefront are the companies engaged in manufacturing and supplying diagnostic products, catering to the need for in-house testing, molecular, and immunodiagnostic solutions in animal healthcare. These are supported and supplemented by the reference laboratories, which provide advanced testing solutions and also assist in managing complex or large-scale diagnostic needs. Also, veterinary practitioners, hospitals, and institutions are important end users that seek advanced diagnostic solutions to inform and support their treatment decisions and patient outcomes. Emerging supportive members of the ecosystem are also technology companies engaged in AI, ML, and cloud-based solutions, entering the mainstream to support improvements in diagnostic accuracy, data interpretation, and integrated workflow solutions. Corresponding to these are also the regulatory organizations that guarantee support and compliance with quality and safety regulations to ensure an important role for the ecosystem to contribute to and facilitate expansion to the companion animal diagnostics market.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Companion Animal Diagnostics Market, By Product

In 2025, consumables held the largest share of the companion animal diagnostics market because they are required for all diagnostic procedures performed in veterinary clinics and laboratories. Consumables have to be replaced from time to time, adding to their high and consistent demand in the market. The growing adoption of in-house analyzers, the rising use of POCT, and the strong focus on routine screenings and preventive measures will drive demand for consumables. The increasing use of diagnostic procedures for pets for infectious disease testing, wellness, and monitoring for chronic diseases will, thus, ensure the largest market share of consumables.

Companion Animal Diagnostics Market, By Technology

In 2025, immunodiagnostics dominated the companion animal diagnostics market due to its widespread use in rapid and accurate detection of infectious diseases, allergies, and chronic conditions in pets. High adoption of ELISA tests, lateral flow assays, and immunoassay analyzers in veterinary clinics and laboratories, along with their cost-effectiveness and quick turnaround time, continues to support segment dominance. Increasing demand for point-of-care testing and preventive veterinary healthcare is further driving the growth of this segment.

Companion Animal Diagnostics Market, By Application

In 2025, clinical pathology held the largest share of the companion animal diagnostics market due to the inclusion of routine tests, such as hematology, urinalysis, and clinical chemistry, which are essential for diagnosing common ailments in companion animals. These tests are used on a large scale for the diagnosis of infections, metabolic and chronic ailments, and are further required for routine health checks. In-house analysis has made the diagnosis of these tests more convenient, thereby increasing the overall market share. Increasing cases of age-related ailments in animals are also adding to the market demand for these tests.

Companion Animal Diagnostics Market, By Animal Type

The dogs segment is expected to account for the largest share of the companion animal market due to the prevalence of dog ownership over other pet animals, thereby driving the demand for diagnostic services. Since dogs are more prone to various health issues, such as infectious diseases, genetic disorders, and chronic conditions such as arthritis and cancer, which increases the need among dog owners to subject their pets to diagnostic procedures. Furthermore, the growing interest in dog-specific health conditions, the expanding scope of diagnostic procedures for canines, and the increasing number of dog owners with access to quality medical treatment are key factors contributing to the dominant share among dogs.

Companion Animal Diagnostics Market, By End User

Veterinary hospitals & clinics accounted for the largest share of the companion animal diagnostics market due to the high volume of patient visits and the widespread use of in-house diagnostic testing for routine screening, disease diagnosis, and treatment monitoring. These facilities are major adopters of hematology, clinical chemistry, immunodiagnostic, and molecular diagnostic systems to support rapid clinical decision-making and improve patient outcomes. Growing investments in advanced veterinary infrastructure and point-of-care testing technologies are further supporting segment growth.

REGION

Asia Pacific to be fastest-growing companion animal diagnostics market during forecast period

The Asia Pacific region is likely to experience the fastest growth rate in the companion animal diagnostics market, driven by rising pet ownership, higher disposable incomes, and increased awareness of veterinary care in countries such as China, India, and Japan. As pet owners become increasingly aware of the need for modern diagnostic techniques in companion animals to prevent diseases, the demand for molecular diagnostics, point-of-care technologies, and in-vitro diagnostics has been increasing. Moreover, the infrastructure of companion animal healthcare, the availability of novel diagnostic techniques, and government support are driving the market's growth. The vast market opportunities in Asia Pacific, along with the entry of emerging companies offering companion animal diagnostics, have accelerated the adoption of novel diagnostics, which will soon put Asia Pacific at the forefront of companion animal care.

companion-animal-diagnostic-market Region

COMPANION ANIMAL DIAGNOSTIC MARKET: COMPANY EVALUATION MATRIX

In the companion animal diagnostics market matrix, IDEXX Laboratories, Inc. (Star) occupies a leading position, driven by its strong market presence, fueled by its broad diagnostic product portfolio and extensive knowledge and expertise in in-clinic and lab-based analysis for the diagnosis and detection of diseases in companion animals. Randox Laboratories Ltd. (Emerging Leader) is strengthening its market presence through its advanced biochip technologies, multiplex testing capabilities, and expanding portfolio of immunodiagnostic solutions for veterinary applications. While other market players continue to expand their diagnostic offerings, IDEXX’s scale and Randox Laboratories’ focus on innovative testing technologies position them prominently in the growing companion animal diagnostics market.

companion-animal-diagnostic-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

IDEXX Laboratories, Inc. (US)
Antech Diagnostics, Inc. (US)
Zoetis Services LLC (US)
FUJIFILM Corporation (Japan)
Thermo Fisher Scientific Inc. (US)
bioMérieux (France)
BioNote (South Korea)
Virbac (France)
Randox Laboratories Ltd. (UK)
INDICAL BIOSCIENCE GmbH (Germany)
Shenzhen Mindray Animal Medical Technology Co., LTD. (China)
Boule (Sweden)
Innovative Diagnostics (US)
MEGACOR Diagnostik GmbH (Austria)
Biogal (Israel)

MARKET SCOPE

REPORT METRIC	DETAILS
Market Size in 2025 (Value)	USD 3.29 BN
Market Size in 2026 (Value)	USD 3.56 BN
Market Size in 2031 (Value)	USD 5.40 BN
CAGR	CAGR of 8.7% from 2026-2031
Years Considered	2024-2031
Base Year	2025
Forecast Period	2026–2031
Units Considered	Value (USD Million), Volume (Thousand Units)
Report Coverage	Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered	By Product: Consumables Instruments By Technology: Immunodiagnostics Clinical Biochemistry Molecular Diagnostics Urinalysis Hematology Other Technologies By Application: Clinical Pathology Bacteriology Virology Parasitology Other Applications By Animal Type: Dogs Cats Horses Other Companion Animals By End User: Veterinary Hospitals & Clinics Veterinary Reference Laboratories Veterinary Research Institutes & Universities Home Care Settings
Regions Covered	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

WHAT IS IN IT FOR YOU: COMPANION ANIMAL DIAGNOSTIC MARKET REPORT CONTENT GUIDE

companion-animal-diagnostic-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST	CUSTOMIZATION DELIVERED	VALUE ADDS
Product Analysis	Comparison of key companion animal diagnostic products and technologies including immunodiagnostics and molecular diagnostics. Highlighted technology adoption trends, test menu expansion, and product differentiation across leading manufacturers	Enabled identification of technology trends, pricing and adoption drivers, and unmet diagnostic needs Supported strategic decisions on product positioning, portfolio expansion, and innovation focus
Company Information	Key players: IDEXX Laboratories, Inc.; Zoetis Services LLC; and Mars, Incorporated Provided insights into product portfolios, competitive positioning, and market presence across major regions	Delivered clarity on competitive intensity, differentiation strategies, and partnership opportunities shaping the companion animal diagnostics landscape
Geographic Analysis	Provided detailed regional analysis of companion animal diagnostics demand across Rest of Asia Pacific, focusing on pet ownership trends, veterinary infrastructure, and diagnostic adoption rates	Supported regional strategy planning by identifying high-growth markets, localization opportunities, and expansion priorities for diagnostic product manufacturers

RECENT DEVELOPMENTS

March 2025 : IDEXX Laboratories introduced IDEXX Cancer Dx, a new diagnostic panel designed to enable early detection of lymphoma in dogs, particularly targeting the millions of dogs in North America that are at heightened risk for cancer.
January 2025 : Antech Diagnostics, Inc. unveiled truRapid FOUR, a new proprietary lateral flow test that screens for important canine vector-borne disease. This test reacts to Anaplasma spp. antibodies, Ehrlichia spp. antibodies, Lyme C6, as well as heartworm antigen in whole blood, serum, or plasma.
December 2024 : Zoetis Services LLC launched Vetscan OptiCell, a screenless, cartridge-based, artificial intelligence-enhanced point-of-care hematology analyzer designed to rapidly analyze complete blood counts with high accuracy in just minutes.

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE

PAGE NO

INTRODUCTION

EXECUTIVE SUMMARY

PREMIUM INSIGHTS

MARKET OVERVIEW

Explore booming pet care trends, AI-driven diagnostics, and untapped market opportunities in veterinary healthcare.

4.1

INTRODUCTION

4.2

MARKET DYNAMICS

4.2.1

DRIVERS

4.2.1.1

GROWTH IN COMPANION ANIMAL POPULATION

4.2.1.2

INCREASING DEMAND FOR PET INSURANCE AND GROWTH IN ANIMAL HEALTHCARE EXPENDITURE

4.2.1.3

GROWING NUMBER OF VETERINARY PRACTITIONERS

4.2.1.4

INCREASING PREVALENCE OF INFECTIOUS, PARASITIC, AND CHRONIC DISEASES IN PETS

4.2.2

RESTRAINTS

4.2.2.1

RISING PET CARE COSTS

4.2.2.2

LIMITED ACCESS TO ADVANCED VETERINARY DIAGNOSTIC SERVICES IN DEVELOPING REGIONS

4.2.3

OPPORTUNITIES

4.2.3.1

GROWING DEMAND FOR RAPID TESTS AND PORTABLE INSTRUMENTS FOR POC DIAGNOSTICS

4.2.3.2

UTILIZATION OF AI AND ML FOR ENHANCED DISEASE DIAGNOSIS

4.2.4

CHALLENGES

4.2.4.1

LOW AWARENESS REGARDING PREVENTIVE DIAGNOSTICS AMONG PET OWNERS IN PRICE-SENSITIVE MARKETS

4.2.4.2

REGULATORY AND REIMBURSEMENT LIMITATIONS IN VETERINARY HEALTHCARE DIAGNOSTICS

4.3

UNMET NEEDS & WHITE SPACES

4.3.1

UNMET NEEDS IN COMPANION ANIMAL DIAGNOSTICS MARKET

4.3.2

WHITE SPACE OPPORTUNITIES

4.4

INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES

4.4.1

INTERCONNECTED MARKETS

4.4.2

CROSS-SECTOR OPPORTUNITIES

4.5

STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

4.5.1

STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

INDUSTRY TRENDS

Navigate industry shifts with strategic insights on market forces, pricing trends, and trade dynamics.

5.1

PORTER’S FIVE FORCES ANALYSIS

5.1.1

THREAT OF NEW ENTRANTS

5.1.2

THREAT OF SUBSTITUTES

5.1.3

BARGAINING POWER OF SUPPLIERS

5.1.4

BARGAINING POWER OF BUYERS

5.1.5

INTENSITY OF COMPETITIVE RIVALRY

5.2

MACROECONOMIC INDICATORS

5.2.1

INTRODUCTION

5.2.2

GDP TRENDS & FORECAST

5.2.3

TRENDS IN GLOBAL HEALTHCARE INDUSTRY

5.2.4

TRENDS IN GLOBAL ANIMAL HEALTH INDUSTRY

5.3

VALUE CHAIN ANALYSIS

5.4

ECOSYSTEM ANALYSIS

5.5

PRICING ANALYSIS

5.5.1

AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023–2025

5.5.2

AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025

5.5.2.1

AVERAGE SELLING PRICE TREND OF RAPID TEST KITS, BY REGION, 2023−2025

5.5.2.2

AVERAGE SELLING PRICE TREND OF ELISA/IMMUNODIAGNOSTIC TEST KITS & REAGENTS, BY REGION, 2023−2025

5.5.2.3

AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY REAGENTS, CLIPS & CARTRIDGES, BY REGION, 2023−2025

5.5.2.4

AVERAGE SELLING PRICE TREND OF BLOOD GLUCOSE STRIPS, BY REGION, 2023−2025

5.5.2.5

AVERAGE SELLING PRICE TREND OF HEMATOLOGY ANALYZERS, BY REGION, 2023−2025

5.6

TRADE ANALYSIS

5.6.1

TRADE DATA FOR HS CODE 9018

5.6.1.1

IMPORT DATA FOR HS CODE 9018

5.6.1.2

EXPORT DATA FOR HS CODE 9018

5.6.2

TRADE DATA FOR HS CODE 3822

5.6.2.1

IMPORT DATA FOR HS CODE 3822

5.6.2.2

EXPORT DATA FOR HS CODE 3822

5.7

KEY CONFERENCES & EVENTS, 2026–2027

5.8

TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES

5.9

INVESTMENT & FUNDING SCENARIO

5.10

SUCCESS STORIES & REAL-WORLD APPLICATIONS

5.10.1

NGS-BASED LIQUID BIOPSY FOR CANINE CANCER DETECTION

5.10.2

ADOPTION OF AI-ENABLED POC DIAGNOSTIC PLATFORM FOR PARASITE DETECTION

5.10.3

DEVELOPMENT OF SNAP 4DX PLUS TEST FOR RAPID VECTOR-BORNE DISEASE DETECTION

5.11

IMPACT OF US TARIFFS—COMPANION ANIMAL DIAGNOSTICS MARKET

5.11.1

INTRODUCTION

5.11.2

KEY TARIFF RATES

5.11.3

PRICE IMPACT ANALYSIS

5.11.4

IMPACT ON COUNTRIES/REGIONS

5.11.5

IMPACT ON END-USE INDUSTRIES

5.11.5.1

VETERINARY HOSPITALS & CLINICS

5.11.5.2

VETERINARY REFERENCE LABORATORIES

5.11.5.3

VETERINARY RESEARCH INSTITUTES & UNIVERSITIES

5.11.5.4

HOME CARE SETTINGS

TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

AI revolutionizes companion animal diagnostics with precision tools and integrated digital ecosystems.

101

6.1

KEY EMERGING TECHNOLOGIES

6.1.1

AI-ENABLED DIAGNOSTICS

6.1.2

PORTABLE INSTRUMENTS FOR POC DIAGNOSTIC SERVICES

6.2

COMPLEMENTARY TECHNOLOGIES

6.2.1

MICROFLUIDIC DEVICES FOR VETERINARY DIAGNOSTICS

6.2.2

CRISPR-BASED MOLECULAR DIAGNOSTICS

6.3

ADJACENT TECHNOLOGIES

6.3.1

WEARABLE BIOSENSORS & REMOTE MONITORING DEVICES

6.3.2

BREATH & SALIVA-BASED DIAGNOSTIC TOOLS

6.4

TECHNOLOGY/PRODUCT ROADMAP

6.4.1

NEAR TERM (2025–2027)

6.4.2

MID-TERM (2028–2030)

6.4.3

LONG TERM (2030+)

6.5

PATENT ANALYSIS

6.5.1

PATENT PUBLICATION TRENDS FOR COMPANION ANIMAL DIAGNOSTIC KITS

6.5.2

JURISDICTION & TOP APPLICANT ANALYSIS

6.6

FUTURE APPLICATIONS

6.6.1

AI-DRIVEN PREDICTIVE DIAGNOSTICS

6.6.2

FULLY INTEGRATED DIGITAL VETERINARY ECOSYSTEMS

6.6.3

PRECISION & PERSONALIZED VETERINARY DIAGNOSTICS

6.6.4

REMOTE & HOME-BASED PET HEALTH MONITORING

6.6.5

AUTOMATED HIGH-THROUGHPUT VETERINARY LABORATORIES

6.7

IMPACT OF AI/GENERATIVE AI ON COMPANION ANIMAL DIAGNOSTICS MARKET

6.7.1

INTRODUCTION

6.7.2

MARKET POTENTIAL IN COMPANION ANIMAL DIAGNOSTIC ECOSYSTEM

6.7.3

AI USE CASES

6.7.4

KEY COMPANIES IMPLEMENTING AI IN COMPANION ANIMAL DIAGNOSTICS MARKET

REGULATORY LANDSCAPE & SUSTAINABILITY INITIATIVES

Navigate global regulations and sustainability standards to enhance eco-friendly diagnostic product compliance.

112

7.1

REGIONAL REGULATIONS & COMPLIANCE

7.1.1

REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

7.1.1.1

NORTH AMERICA

7.1.1.2

EUROPE

7.1.1.3

REST OF THE WORLD

7.1.2

INDUSTRY STANDARDS

7.2

SUSTAINABILITY INITIATIVES

7.2.1

RECYCLED AND ECO-FRIENDLY MATERIALS FOR COMPANION ANIMAL DIAGNOSTIC PRODUCTS

7.2.2

SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES

7.2.3

CERTIFICATIONS, LABELING, AND ECO-STANDARDS

CUSTOMER LANDSCAPE & BUYER BEHAVIOR

Unlock insights into decision-makers' criteria and unmet needs shaping market profitability.

119

8.1

KEY STAKEHOLDERS & BUYING CRITERIA

8.1.1

KEY STAKEHOLDERS IN BUYING PROCESS

8.1.2

BUYING CRITERIA

8.2

CUSTOMER LANDSCAPE & BUYER BEHAVIOR

8.2.1

DECISION-MAKING PROCESS

8.2.2

ADOPTION BARRIERS & INTERNAL CHALLENGES

8.2.3

UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES

8.2.4

MARKET PROFITABILITY

COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 5 Data Tables

124

9.1

INTRODUCTION

9.2

CONSUMABLES

9.2.1

RECURRING NATURE TO BOOST DEMAND

9.3

INSTRUMENTS

9.3.1

INCREASING DEMAND FOR POC ANALYZERS TO DRIVE MARKET

COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million and Units | 81 Data Tables

131

10.1

INTRODUCTION

10.2

IMMUNODIAGNOSTICS

10.2.1

LATERAL FLOW ASSAYS

10.2.1.1

RAPID TESTS

10.2.1.1.1

GROWING PREVALENCE OF INFECTIOUS DISEASES IN PETS TO FUEL DEMAND

10.2.1.1.2

GLOBAL VOLUME ANALYSIS OF RAPID TESTS, 2024–2031 (THOUSAND UNITS)

10.2.1.2

STRIP READERS

10.2.1.2.1

ADVANCEMENTS IN DIGITAL AND AI-ENABLED DIAGNOSTICS TO SUPPORT ADOPTION

10.2.1.2.2

GLOBAL VOLUME ANALYSIS OF STRIP READERS, 2024–2031 (THOUSAND UNITS)

10.2.2

ELISA TESTS

10.2.2.1

HIGHER SENSITIVITY AND SPECIFICITY OF ELISA TESTING TO SUPPORT MARKET EXPANSION

10.2.3

ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS

10.2.3.1

RISING INCIDENCE OF ALLERGIES AND DERMATOLOGICAL CONDITIONS TO FUEL MARKET GROWTH

10.2.4

IMMUNOASSAY ANALYZERS

10.2.4.1

INCREASING AUTOMATION IN VETERINARY DIAGNOSTICS TO DRIVE MARKET GROWTH

10.2.5

RADIOIMMUNOASSAYS

10.2.5.1

GROWING DEMAND FOR SENSITIVE HORMONE AND ENDOCRINE TESTING TO FUEL MARKET

10.2.6

OTHER IMMUNODIAGNOSTICS PRODUCTS

10.3

CLINICAL BIOCHEMISTRY

10.3.1

CLINICAL CHEMISTRY ANALYSIS

10.3.1.1

CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES

10.3.1.1.1

INCREASING UTILIZATION OF CONSUMABLE-BASED DIAGNOSTIC WORKFLOWS TO FUEL MARKET

10.3.1.1.2

GLOBAL VOLUME ANALYSIS OF CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES, 2024–2031 (THOUSAND UNITS)

10.3.1.2

CLINICAL CHEMISTRY ANALYZERS

10.3.1.2.1

GROWING ADOPTION OF IN-HOUSE VETERINARY DIAGNOSTICS TO DRIVE ANALYZER DEMAND

10.3.1.2.2

GLOBAL VOLUME ANALYSIS OF CLINICAL CHEMISTRY ANALYZERS, 2024–2031 (THOUSAND UNITS)

10.3.2

BLOOD GAS & ELECTROLYTE ANALYSIS

10.3.2.1

BLOOD GAS AND ELECTROLYTE REAGENTS, CLIPS, AND CARTRIDGES

10.3.2.1.1

RISING DEMAND FOR RAPID POINT-OF-CARE CONSUMABLES TO BOOST MARKET

10.3.2.1.2

GLOBAL VOLUME ANALYSIS OF BLOOD GAS & ELECTROLYTE REAGENTS, CLIPS, AND CARTRIDGES, 2024–2031 (THOUSAND UNITS)

10.3.2.2

BLOOD GAS & ELECTROLYTE ANALYZERS

10.3.2.2.1

INCREASING ADOPTION OF COMPACT CRITICAL-CARE ANALYZERS IN VETERINARY CLINICS TO DRIVE MARKET

10.3.2.2.2

GLOBAL VOLUME ANALYSIS OF BLOOD GAS & ELECTROLYTE ANALYZERS, 2024–2031 (THOUSAND UNITS)

10.3.3

GLUCOSE MONITORING

10.3.3.1

BLOOD GLUCOSE STRIPS

10.3.3.1.1

INCREASING HOME-BASED DIABETES MANAGEMENT TO FUEL MARKET

10.3.3.1.2

GLOBAL VOLUME ANALYSIS OF BLOOD GLUCOSE STRIPS, 2024–2031 (THOUSAND UNITS)

10.3.3.2

GLUCOSE MONITORS

10.3.3.2.1

ADVANCEMENTS IN PORTABLE AND CONTINUOUS GLUCOSE MONITORING TECHNOLOGIES TO DRIVE MARKET GROWTH

10.3.3.2.2

GLOBAL VOLUME ANALYSIS OF GLUCOSE MONITORS, 2024–2031 (THOUSAND UNITS)

10.3.3.3

URINE GLUCOSE STRIPS

10.3.3.3.1

COST-EFFECTIVE AND NON-INVASIVE DIABETES SCREENING TO PROPEL MARKET

10.3.3.3.2

GLOBAL VOLUME ANALYSIS OF URINE GLUCOSE STRIPS, 2024–2031 (THOUSAND UNITS)

10.4

MOLECULAR DIAGNOSTICS

10.4.1

PCR TESTS

10.4.1.1

INCREASING PREVALENCE OF INFECTIOUS DISEASES IN COMPANION ANIMALS TO SUPPORT GROWTH

10.4.2

MICROARRAYS

10.4.2.1

GROWING FOCUS ON GENOMIC PROFILING AND MULTIPLEX TESTING TO DRIVE MARKET

10.4.3

NUCLEIC ACID SEQUENCING

10.4.3.1

EXPANDING APPLICATIONS OF GENOMIC ANALYSIS IN VETERINARY MEDICINE TO DRIVE DEMAND

10.4.4

OTHER MOLECULAR DIAGNOSTICS PRODUCTS

10.5

URINALYSIS

10.5.1

URINALYSIS CLIPS & CARTRIDGES

10.5.1.1

GROWING USE OF CONSUMABLE-BASED URINE TESTING WORKFLOWS TO DRIVE GROWTH

10.5.2

URINE ANALYZERS

10.5.2.1

INCREASING AUTOMATION IN VETERINARY URINALYSIS TESTING TO SUPPORT MARKET GROWTH

10.5.3

URINE TEST STRIPS

10.5.3.1

RISING DEMAND FOR RAPID AND COST-EFFECTIVE URINE SCREENING TESTS TO DRIVE MARKET

10.6

HEMATOLOGY

10.6.1

HEMATOLOGY CARTRIDGES

10.6.1.1

RISING USE OF DISPOSABLE CONSUMABLES IN AUTOMATED HEMATOLOGY WORKFLOWS TO FUEL DEMAND

10.6.2

HEMATOLOGY ANALYZERS

10.6.2.1

GROWING DEMAND FOR RAPID COMPLETE BLOOD COUNT TESTING TO SUPPORT MARKET GROWTH

10.7

OTHER TECHNOLOGIES

COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 6 Data Tables

203

11.1

INTRODUCTION

11.2

CLINICAL PATHOLOGY

11.2.1

INCREASING PREVENTIVE HEALTH SCREENING AND CHRONIC DISEASE MONITORING DRIVES DEMAND

11.3

BACTERIOLOGY

11.3.1

RISING BACTERIAL INFECTIONS AND ANTIMICROBIAL RESISTANCE CONCERNS BOOST MARKET GROWTH

11.4

VIROLOGY

11.4.1

GROWING PREVALENCE OF COMPANION ANIMAL VIRAL DISEASES DRIVES GROWTH

11.5

PARASITOLOGY

11.5.1

INCREASING PARASITIC AND VECTOR-BORNE DISEASE BURDEN SUPPORTS DIAGNOSTIC ADOPTION

11.6

OTHER APPLICATIONS

COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 8 Data Tables

215

12.1

INTRODUCTION

12.2

DOGS

12.2.1

RISING PREVALENCE OF CANINE CHRONIC AND VECTOR-BORNE DISEASES DRIVES DIAGNOSTIC DEMAND

12.3

CATS

12.3.1

GROWING AWARENESS OF FELINE INFECTIOUS AND KIDNEY DISEASES BOOSTS MARKET GROWTH

12.4

HORSE

12.4.1

INCREASING EQUINE HEALTH MONITORING SUPPORTS DIAGNOSTIC ADOPTION

12.5

OTHER COMPANION ANIMALS

COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 5 Data Tables

226

13.1

INTRODUCTION

13.2

VETERINARY HOSPITALS & CLINICS

13.2.1

EXPANDING ADOPTION OF IN-HOUSE POINT-OF-CARE DIAGNOSTIC SOLUTIONS TO DRIVE MARKET

13.3

VETERINARY REFERENCE LABORATORIES

13.3.1

RISING DEMAND FOR SPECIALIZED AND HIGH-COMPLEXITY VETERINARY DIAGNOSTIC TESTING TO PROPEL MARKET

13.4

VETERINARY RESEARCH INSTITUTES & UNIVERSITIES

13.4.1

INCREASING RESEARCH FOCUS ON PRECISION AND MOLECULAR VETERINARY DIAGNOSTICS TO SUPPORT GROWTH

13.5

HOME CARE SETTINGS

13.5.1

GROWING ADOPTION OF AT-HOME PET HEALTH MONITORING AND DIAGNOSTIC TECHNOLOGIES TO BOOST DEMAND

COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION

Comprehensive coverage of 8 Regions with country-level deep-dive of 22 Countries | 497 Data Tables.

235

14.1

INTRODUCTION

14.2

NORTH AMERICA

14.2.1

MACROECONOMIC OUTLOOK FOR NORTH AMERICA

14.2.2

NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031

14.2.3

14.2.3.1

RISING PREVENTIVE PET HEALTHCARE SPENDING TO DRIVE MARKET

14.2.4

CANADA

14.2.4.1

INCREASING VETERINARY VISITS AND GROWING PET POPULATION TO DRIVE MARKET

14.3

EUROPE

14.3.1

MACROECONOMIC OUTLOOK FOR EUROPE

14.3.2

EUROPE: VOLUME ANALYSIS, BY PRODUCT, 2024–2031

14.3.3

GERMANY

14.3.3.1

LARGE COMPANION ANIMAL POPULATION AND PREMIUM VETERINARY CARE FUEL MARKET GROWTH

14.3.4

14.3.4.1

HIGH VETERINARY EXPENDITURE AND RISING CHRONIC PET DISEASES SUPPORT DIAGNOSTICS DEMAND

14.3.5

FRANCE

14.3.5.1

WILLINGNESS OF PET OWNERS TO SPEND ON PET HEALTH TO DRIVE MARKET

14.3.6

ITALY

14.3.6.1

EXPANSION OF VETERINARY SERVICES SUPPORTS MARKET GROWTH

14.3.7

SPAIN

14.3.7.1

GROWING PET CARE ECONOMY AND ANIMAL WELFARE INITIATIVES TO FUEL MARKET

14.3.8

NETHERLANDS

14.3.8.1

DEVELOPMENTS IN VETERINARY DIAGNOSTIC PRODUCTS TO SUPPORT MARKET GROWTH

14.3.9

SWEDEN

14.3.9.1

GROWING COMPANION ANIMAL CARE AND ADVANCED VETERINARY INFRASTRUCTURE SUPPORTING MARKET GROWTH

14.3.10

POLAND

14.3.10.1

EXPANDING VETERINARY INFRASTRUCTURE AND RISING PET OWNERSHIP SUPPORT MARKET DEVELOPMENT

14.3.11

REST OF EUROPE

14.4

ASIA PACIFIC

14.4.1

MACROECONOMIC OUTLOOK FOR ASIA PACIFIC

14.4.2

ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT, 2024–2031

14.4.3

CHINA

14.4.3.1

GROWING URBAN PET POPULATION AND RISING ADOPTION OF PET INSURANCE TO PROPEL MARKET

14.4.4

JAPAN

14.4.4.1

AGING PET POPULATION AND PREMIUM VETERINARY CARE TO SUPPORT MARKET GROWTH

14.4.5

INDIA

14.4.5.1

EXPANDING PET CARE INDUSTRY AND RISING PREVENTIVE HEALTHCARE AWARENESS FUEL MARKET GROWTH

14.4.6

AUSTRALIA

14.4.6.1

HIGH VETERINARY EXPENDITURE AND STRONG PET INSURANCE PENETRATION TO SUPPORT MARKET GROWTH

14.4.7

SOUTH KOREA

14.4.7.1

DIGITAL VETERINARY HEALTHCARE EXPANSION TO DRIVE MARKET

14.4.8

THAILAND

14.4.8.1

URBAN PET ADOPTION AND IMPROVING VETERINARY INFRASTRUCTURE TO DRIVE MARKET

14.4.9

NEW ZEALAND

14.4.9.1

STRONG ANIMAL WELFARE CULTURE AND PREVENTIVE CARE TRENDS SUPPORT MARKET EXPANSION

14.4.10

REST OF ASIA PACIFIC

14.5

LATIN AMERICA

14.5.1

MACROECONOMIC OUTLOOK FOR LATIN AMERICA

14.5.2

LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031

14.5.3

BRAZIL

14.5.3.1

MASSIVE COMPANION ANIMAL POPULATION TO BOOST DEMAND

14.5.4

MEXICO

14.5.4.1

HIGH PET OWNERSHIP AND EXPANDING VETERINARY SERVICES TO SUPPORT MARKET GROWTH

14.5.5

ARGENTINA

14.5.5.1

STRONG PET HUMANIZATION AND PREVENTIVE HEALTHCARE TRENDS SUPPORT MARKET GROWTH

14.5.6

REST OF LATIN AMERICA

14.6

MIDDLE EAST & AFRICA

14.6.1

MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

14.6.2

MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031

14.6.3

GCC COUNTRIES

14.6.3.1

KINGDOM OF SAUDI ARABIA (KSA)

14.6.3.1.1

GOVERNMENT INITIATIVES TO DRIVE MARKET GROWTH

14.6.3.2

UNITED ARAB EMIRATES (UAE)

14.6.3.2.1

PREMIUM VETERINARY SERVICES AND RISING PET OWNERSHIP TO DRIVE MARKET

14.6.3.3

REST OF GCC COUNTRIES

14.6.4

REST OF MIDDLE EAST & AFRICA

COMPETITIVE LANDSCAPE

Gain strategic insights on market leaders and emerging competitors shaping the industry's future landscape.

451

15.1

OVERVIEW

15.2

KEY PLAYER STRATEGIES/RIGHT TO WIN

15.3

REVENUE ANALYSIS, 2021−2025

15.4

MARKET SHARE ANALYSIS, 2025

15.4.1

RANKING OF KEY MARKET PLAYERS

15.4.2

US MARKET SHARE ANALYSIS, 2025

15.4.3

EUROPE MARKET SHARE ANALYSIS, 2025

15.5

COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025

15.5.1

STARS

15.5.2

EMERGING LEADERS

15.5.3

PERVASIVE PLAYERS

15.5.4

PARTICIPANTS

15.5.5

COMPANY FOOTPRINT: KEY PLAYERS, 2025

15.5.5.1

COMPANY FOOTPRINT

15.5.5.2

REGION FOOTPRINT

15.5.5.3

PRODUCT FOOTPRINT

15.5.5.4

TECHNOLOGY FOOTPRINT

15.5.5.5

ANIMAL TYPE FOOTPRINT

15.6

COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025

15.6.1

PROGRESSIVE COMPANIES

15.6.2

RESPONSIVE COMPANIES

15.6.3

DYNAMIC COMPANIES

15.6.4

STARTING BLOCKS

15.6.5

COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025

15.6.5.1

DETAILED LIST OF KEY STARTUPS/SMES

15.6.5.2

COMPETITIVE BENCHMARKING OF KEY STARTUPS

15.7

BRAND/PRODUCT COMPARISON

15.8

R&D EXPENDITURE OF KEY PLAYERS

15.9

COMPANY VALUATION & FINANCIAL METRICS

15.9.1

FINANCIAL METRICS

15.9.2

COMPANY VALUATION

15.10

COMPETITIVE SCENARIO

15.10.1

PRODUCT LAUNCHES & ENHANCEMENTS

15.10.2

DEALS

15.10.3

EXPANSIONS

15.10.4

OTHER DEVELOPMENTS

COMPANY PROFILES

In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)

476

16.1

KEY PLAYERS

16.1.1

IDEXX LABORATORIES, INC.

16.1.1.1

BUSINESS OVERVIEW

16.1.1.2

PRODUCTS OFFERED

16.1.1.3

RECENT DEVELOPMENTS

16.1.1.3.1

PRODUCT LAUNCHES & ENHANCEMENTS

16.1.1.4

MNM VIEW

16.1.1.4.1

KEY STRENGTHS

16.1.1.4.2

STRATEGIC CHOICES

16.1.1.4.3

WEAKNESSES & COMPETITIVE THREATS

16.1.2

ANTECH DIAGNOSTICS, INC.

16.1.3

ZOETIS SERVICES LLC

16.1.4

FUJIFILM CORPORATION

16.1.5

THERMO FISHER SCIENTIFIC INC.

16.1.6

BIOMÉRIEUX

16.1.7

BIONOTE

16.1.8

VIRBAC

16.1.9

RANDOX LABORATORIES LTD.

16.1.10

INDICAL BIOSCIENCE GMBH

16.1.11

SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.

16.1.12

BOULE

16.1.13

INNOVATIVE DIAGNOSTICS

16.1.14

MEGACOR DIAGNOSTIK GMBH

16.1.15

BIOGAL

16.2

OTHER PLAYERS

16.2.1

GOLD STANDARD DIAGNOSTICS

16.2.2

AGROLABO S.P.A.

16.2.3

PRECISION BIOSENSOR, INC.

16.2.4

SKYLA CORPORATION

16.2.5

FASSISI, GMBH

16.2.6

WOODLEY EQUIPMENT COMPANY LTD

16.2.7

BIOPANDA REAGENTS LTD

16.2.8

SKYER, INC.

16.2.9

RING BIOTECHNOLOGY CO., LTD.

16.2.10

SHENZHEN BIOEASY BIOTECHNOLOGY, INC.

RESEARCH METHODOLOGY

548

17.1

RESEARCH DATA

17.2

RESEARCH METHODOLOGY DESIGN

17.2.1

SECONDARY DATA

17.2.1.1

KEY DATA FROM SECONDARY SOURCES

17.2.2

PRIMARY DATA

17.2.2.1

KEY DATA FROM PRIMARY SOURCES

17.2.2.2

KEY INDUSTRY INSIGHTS

17.3

MARKET SIZE ESTIMATION

17.3.1

BOTTOM-UP APPROACH

17.4

MARKET BREAKDOWN AND DATA TRIANGULATION

17.5

MARKET SHARE ANALYSIS

17.5.1

RESEARCH ASSUMPTIONS

17.5.2

GROWTH RATE ASSUMPTIONS

17.6

RISK ASSESSMENT

17.7

RESEARCH LIMITATIONS

17.7.1

METHODOLOGY-RELATED LIMITATIONS

17.7.2

SCOPE-RELATED LIMITATIONS

APPENDIX

564

18.1

DISCUSSION GUIDE

18.2

KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

18.3

CUSTOMIZATION OPTIONS

18.3.1

PRODUCT ANALYSIS

18.3.2

Methodology

This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

Secondary Research

This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the companion animal diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

Primary Research

In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the companion animal diagnostics market. Primary sources from the demand side include R&D product development teams in animal health companies, veterinary clinicians, diagnostic laboratory managers, and procurement heads at veterinary reference laboratories.

Companion Animal Diagnostic Market
Size, and Share

Note: C-level executives include CEOs, COOs, CTOs, and VPs. Other designations include sales, marketing, and product managers.
Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the companion animal diagnostics market was determined through data triangulation across three approaches, as described below. After each approach, the weighted average of the three was calculated based on the level of assumptions used in each.

Companion Animal Diagnostic Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed as applicable to complete the overall market engineering process and obtain exact statistics for all segments and subsegments.

Market Definition

Companion animal diagnostics use plasma, serum, blood, urine, feces, and tissue samples to detect, monitor, and manage diseases and health conditions in dogs, cats, horses, and other household pets. The companion animal diagnostics market includes diagnostic instruments, test kits, reagents, and consumables used in veterinary clinics and laboratories, covering technologies such as clinical chemistry analyzers, hematology analyzers, immunodiagnostics and ELISA test kits, urinalysis systems, molecular diagnostic assays, glucose monitoring systems, and blood gas–electrolyte analyzers. These products support routine wellness screening, disease diagnosis, treatment monitoring, and preventive healthcare in companion animals.

Key Stakeholders

Companion animal diagnostic manufacturers
Companion animal diagnostic distributors and suppliers
Companion animal R&D companies
Veterinary reference laboratories
Veterinary hospitals and clinics
Veterinary universities and research institutes
Government associations
Market research and consulting firms
Venture capitalists and investors
Distributors, channel partners, and third-party suppliers

Report Objectives

To define, describe, segment, and forecast the companion animal diagnostics market by product, technology, application, animal type, end user, and region
To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall companion animal diagnostics market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To forecast the size of the companion animal diagnostics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
To profile the key players in the companion animal diagnostics market and comprehensively analyze their core competencies and market shares
To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

Available customizations:

Based on the given market data, MarketsandMarkets offers customization to meet your company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

Further breakdown of the Rest of European companion animal diagnostics market into Austria, Finland, Switzerland, and other countries
Further breakdown of the Rest of Latin American companion animal diagnostics market into Colombia, Chile, and other countries

Competitive Landscape Assessment

Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the companion animal diagnostics market
Competitive leadership mapping for established players in the US

Companion Animal Diagnostic Market by Product (Consumable, Instrument), Technology (Immunodiagnostic, ELISA, PCR Test, Urinalysis, Hematology), Animal Type (Dog, Cat), Application (Clinical Pathology, Virology), End User - Global Forecast to 2031

COMPANION ANIMAL DIAGNOSTIC MARKET SIZE, SHARE & GROWTH SNAPSHOT

KEY TAKEAWAYS

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

MARKET DYNAMICS

Driver: Growing companion animal ownership

Restraint: High cost of diagnostic devices

Opportunity: Growing demand for rapid tests and portable instruments for PoC diagnostics

Challenge: Shortage of veterinary practitioners in emerging markets

COMPANION ANIMAL DIAGNOSTIC MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

MARKET ECOSYSTEM

MARKET SEGMENTS

Companion Animal Diagnostics Market, By Product

Companion Animal Diagnostics Market, By Technology

Companion Animal Diagnostics Market, By Application

Companion Animal Diagnostics Market, By Animal Type

Companion Animal Diagnostics Market, By End User

REGION

Asia Pacific to be fastest-growing companion animal diagnostics market during forecast period

COMPANION ANIMAL DIAGNOSTIC MARKET: COMPANY EVALUATION MATRIX

KEY MARKET PLAYERS

MARKET SCOPE

WHAT IS IN IT FOR YOU: COMPANION ANIMAL DIAGNOSTIC MARKET REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS

RECENT DEVELOPMENTS

Table of Contents

Methodology

Secondary Research

Primary Research

Market Size Estimation

Data Triangulation

Market Definition

Key Stakeholders

Report Objectives

Available customizations:

TABLE OF CONTENTS

METHODOLOGY

Need a Tailored Report?

Adjacent Markets

Personalize This Research

Let Us Help You

TESTIMONIALS

JAYANT RAJPUROHIT

SFI Health,

BEATRIZ DE LA CALLE

Qualicaps,

Bob Williams,

Bracco Diagnostics Inc.,

Cody Coonradt,

3M Health Information Systems,

Growth opportunities and latent adjacency in Companion Animal Diagnostic Market